BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sahoo AK, Dandapat J, Dash UC, Kanhar S. Features and outcomes of drugs for combination therapy as multi-targets strategy to combat Alzheimer's disease. J Ethnopharmacol 2018;215:42-73. [PMID: 29248451 DOI: 10.1016/j.jep.2017.12.015] [Cited by in Crossref: 68] [Cited by in F6Publishing: 59] [Article Influence: 13.6] [Reference Citation Analysis]
Number Citing Articles
1 Wang Y, Meng X, Guan Y, Zhao Z, Tao L, Gong J, Liu X, Zhao Y, Shan X. The effects of dietary supplementation of ginseng stem and leaf saponins on the antioxidant capacity, immune response, and disease resistance of crucian carp, Carassius auratus. Fish Physiol Biochem 2022. [DOI: 10.1007/s10695-022-01142-9] [Reference Citation Analysis]
2 Lee D, Lee VM, Hur SK. Manipulation of the diet–microbiota–brain axis in Alzheimer’s disease. Front Neurosci 2022;16. [DOI: 10.3389/fnins.2022.1042865] [Reference Citation Analysis]
3 Ajenikoko MK, Ajagbe AO, Onigbinde OA, Okesina AA, Tijani-adekilekun A. Review of Alzheimer’s Disease drugs and their relationship with neuron-glia interaction. IBRO Neuroscience Reports 2022. [DOI: 10.1016/j.ibneur.2022.11.005] [Reference Citation Analysis]
4 Matošević A, Knežević A, Zandona A, Maraković N, Kovarik Z, Bosak A. Design, Synthesis and Biological Evaluation of Biscarbamates as Potential Selective Butyrylcholinesterase Inhibitors for the Treatment of Alzheimer's Disease. Pharmaceuticals (Basel) 2022;15:1220. [PMID: 36297332 DOI: 10.3390/ph15101220] [Reference Citation Analysis]
5 Tsai Y, Kao S, Cheng C. Medicinal Herbs and Their Derived Ingredients Protect against Cognitive Decline in In Vivo Models of Alzheimer’s Disease. IJMS 2022;23:11311. [DOI: 10.3390/ijms231911311] [Reference Citation Analysis]
6 Krishnan N, Mariappanadar V, Dhanabalan AK, Devadasan V, Gopinath SCB, Raman P. Purification, identification and in silico models of alkaloids from Nardostachys jatamansi — bioactive compounds for neurodegenerative diseases. Biomass Conv Bioref . [DOI: 10.1007/s13399-022-03237-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Liu G, Wang Z, Cui X, Yang S. Component analysis of Xylaria sp. L1 sporocarps after solid-state fermentation by okara and its safety evaluation in mice and rats. Nat Prod Res 2022;:1-5. [PMID: 35749649 DOI: 10.1080/14786419.2022.2092734] [Reference Citation Analysis]
8 Tikhonova MA, Chang H, Singh SK, Vieau D. Editorial: Experimental and Innovative Approaches to Multi-Target Treatment of Parkinson's and Alzheimer's Diseases. Front Neurosci 2022;16:910020. [DOI: 10.3389/fnins.2022.910020] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
9 Myers AL. Metabolism of the areca alkaloids - toxic and psychoactive constituents of the areca (betel) nut. Drug Metab Rev 2022;:1-33. [PMID: 35543097 DOI: 10.1080/03602532.2022.2075010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Kirsch SH, Haeckl FPJ, Müller R. Beyond the approved: target sites and inhibitors of bacterial RNA polymerase from bacteria and fungi. Nat Prod Rep 2022. [PMID: 35507039 DOI: 10.1039/d1np00067e] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Lan Q, Guan P, Huang C, Huang S, Zhou P, Zhang C. Arecoline Induces an Excitatory Response in Ventral Tegmental Area Dopaminergic Neurons in Anesthetized Rats. Front Pharmacol 2022;13:872212. [DOI: 10.3389/fphar.2022.872212] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 You M, Wang K, Pan Y, Tao L, Ma Q, Zhang G, Hu F. Combined royal jelly 10-hydroxydecanoic acid and aspirin has a synergistic effect against memory deficit and neuroinflammation. Food Funct 2022;13:2336-53. [PMID: 35142767 DOI: 10.1039/d1fo02397g] [Reference Citation Analysis]
13 Taqui R, Debnath M, Ahmed S, Ghosh A. Advances on plant extracts and phytocompounds with acetylcholinesterase inhibition activity for possible treatment of Alzheimer's disease. Phytomedicine Plus 2022;2:100184. [DOI: 10.1016/j.phyplu.2021.100184] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
14 Dash UC, Swain SK, Kanhar S, Banjare P, Roy PP, Dandapat J, Sahoo AK. The modulatory role of prime identified compounds in Geophila repens in mitigating scopolamine-induced neurotoxicity in experimental rats of Alzheimer's disease via attenuation of cholinesterase, β-secretase, MAPt levels and inhibition of oxidative stress imparts inflammation. J Ethnopharmacol 2022;282:114637. [PMID: 34534598 DOI: 10.1016/j.jep.2021.114637] [Reference Citation Analysis]
15 Dhahri M, Alghrably M, Mohammed HA, Badshah SL, Noreen N, Mouffouk F, Rayyan S, Qureshi KA, Mahmood D, Lachowicz JI, Jaremko M, Emwas AH. Natural Polysaccharides as Preventive and Therapeutic Horizon for Neurodegenerative Diseases. Pharmaceutics 2021;14:1. [PMID: 35056897 DOI: 10.3390/pharmaceutics14010001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
16 Sun X, Suo X, Xia X, Yu C, Dou Y. Dimethyl Fumarate is a Potential Therapeutic Option for Alzheimer's Disease. J Alzheimers Dis 2021. [PMID: 34842188 DOI: 10.3233/JAD-215074] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
17 Smirnova AA, Prakhova LN, Ilves AG. Immunopathogenesis and immunotherapeutic approaches of neurodegenerative and cerebrovascular diseases with cognitive impairment. The current state of the problem and prospects. РНЖ 2021;26:4-15. [DOI: 10.30629/2658-7947-2021-26-5-4-15] [Reference Citation Analysis]
18 Tikhonova MA, Amstislavskaya TG, Ho YJ, Akopyan AA, Tenditnik MV, Ovsyukova MV, Bashirzade AA, Dubrovina NI, Aftanas LI. Neuroprotective Effects of Ceftriaxone Involve the Reduction of Aβ Burden and Neuroinflammatory Response in a Mouse Model of Alzheimer's Disease. Front Neurosci 2021;15:736786. [PMID: 34658774 DOI: 10.3389/fnins.2021.736786] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
19 Han J, Li L, Su M, Heng W, Wei Y, Gao Y, Qian S. Deaggregation and Crystallization Inhibition by Small Amount of Polymer Addition for a Co-Amorphous Curcumin-Magnolol System. Pharmaceutics 2021;13:1725. [PMID: 34684018 DOI: 10.3390/pharmaceutics13101725] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
20 Gao Y, Zhang N, Lv C, Li N, Li X, Li W. lncRNA SNHG1 Knockdown Alleviates Amyloid-β-Induced Neuronal Injury by Regulating ZNF217 via Sponging miR-361-3p in Alzheimer's Disease. J Alzheimers Dis 2020;77:85-98. [PMID: 32741808 DOI: 10.3233/JAD-191303] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
21 Bae M, Han SY, Kim ES, You BH, Kim YM, Cho J, Chin YW, Choi YH. Effect of Water Extract of Mangosteen Pericarp on Donepezil Pharmacokinetics in Mice. Molecules 2021;26:5246. [PMID: 34500680 DOI: 10.3390/molecules26175246] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Torres KM, Delgado AS, Serrano ER, Falcón-Cruz NV, Meléndez A, Ramos I, Du D, Oyola R. Gallium nanoparticles as novel inhibitors of Aβ40 aggregation. Mater Adv 2021;2:5471-8. [PMID: 34458846 DOI: 10.1039/d1ma00461a] [Reference Citation Analysis]
23 Ghanem SS, Fayed HS, Zhu Q, Lu JH, Vaikath NN, Ponraj J, Mansour S, El-Agnaf OMA. Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity. Molecules 2021;26:3736. [PMID: 34205249 DOI: 10.3390/molecules26123736] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
24 Das R, Rauf A, Akhter S, Islam MN, Emran TB, Mitra S, Khan IN, Mubarak MS. Role of Withaferin A and Its Derivatives in the Management of Alzheimer's Disease: Recent Trends and Future Perspectives. Molecules 2021;26:3696. [PMID: 34204308 DOI: 10.3390/molecules26123696] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
25 Pohanka M. Inhibitors of Cholinesterases in Pharmacology: the Current Trends. Mini Rev Med Chem 2020;20:1532-42. [PMID: 31656151 DOI: 10.2174/1389557519666191018170908] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
26 Babaee S, Chehardoli G, Akbarzadeh T, Zolfigol MA, Mahdavi M, Rastegari A, Homayouni Moghadam F, Najafi Z. Design, Synthesis, and Molecular Docking of Some Novel Tacrine Based Cyclopentapyranopyridine- and Tetrahydropyranoquinoline-Kojic Acid Derivatives as Anti-Acetylcholinesterase Agents. Chem Biodivers 2021;18:e2000924. [PMID: 33861892 DOI: 10.1002/cbdv.202000924] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
27 Alhawarri MB, Dianita R, Razak KNA, Mohamad S, Nogawa T, Wahab HA. Antioxidant, Anti-Inflammatory, and Inhibition of Acetylcholinesterase Potentials of Cassia timoriensis DC. Flowers. Molecules 2021;26:2594. [PMID: 33946788 DOI: 10.3390/molecules26092594] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
28 Su D, Chai Y, Yang J, Wang X, Liu Y, Ma J, Tang X, Mishra C, Chandra SR, Yue W, Ai J. Lentivirus-Carried microRNA-195 Rescues Memory Deficits of Alzheimer's Disease Transgenic Mouse by Attenuating the Generation of Amyloid Plaques. Front Pharmacol 2021;12:633805. [PMID: 33981225 DOI: 10.3389/fphar.2021.633805] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Dong H, Zhang J, Rong H, Zhang X, Dong M. Paeoniflorin and Plycyrrhetinic Acid Synergistically Alleviate MPP+/MPTP-Induced Oxidative Stress through Nrf2-Dependent Glutathione Biosynthesis Mechanisms. ACS Chem Neurosci 2021;12:1100-11. [PMID: 33724802 DOI: 10.1021/acschemneuro.0c00544] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
30 Boiangiu RS, Mihasan M, Gorgan DL, Stache BA, Hritcu L. Anxiolytic, Promnesic, Anti-Acetylcholinesterase and Antioxidant Effects of Cotinine and 6-Hydroxy-L-Nicotine in Scopolamine-Induced Zebrafish (Danio rerio) Model of Alzheimer's Disease. Antioxidants (Basel) 2021;10:212. [PMID: 33535660 DOI: 10.3390/antiox10020212] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
31 Kong YR, Tay KC, Su YX, Wong CK, Tan WN, Khaw KY. Potential of Naturally Derived Alkaloids as Multi-Targeted Therapeutic Agents for Neurodegenerative Diseases. Molecules 2021;26:728. [PMID: 33573300 DOI: 10.3390/molecules26030728] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
32 Wang Y, Hu R, Guo Y, Qin W, Zhang X, Hua L, Yang Y. Preparation, evaluation, and in vitro release of chitosan-alginate tanshinone self-microemulsifying sustained-release microcapsules. Technol Health Care 2021;29:687-95. [PMID: 33386833 DOI: 10.3233/THC-202529] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
33 Tikhonova MA, Shoeva OY, Tenditnik MV, Ovsyukova MV, Akopyan AA, Dubrovina NI, Amstislavskaya TG, Khlestkina EK. Evaluating the Effects of Grain of Isogenic Wheat Lines Differing in the Content of Anthocyanins in Mouse Models of Neurodegenerative Disorders. Nutrients 2020;12:E3877. [PMID: 33353018 DOI: 10.3390/nu12123877] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
34 Hv S, Raj A, K G, S C, K S. Kinetics and computational analysis of cholinesterase inhibition by REVERC3, a bisdemethoxycurcumin-rich Curcuma longa extract: Relevance to the treatment of Alzheimer's disease. SAGE Open Med 2020;8:2050312120973499. [PMID: 33282298 DOI: 10.1177/2050312120973499] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
35 Siafaka PI, Bülbül EÖ, Mutlu G, Okur ME, Karantas ID, Okur NÜ. Transdermal Drug Delivery Systems and their Potential in Alzheimer’s Disease Management. CNSNDDT 2020;19:360-73. [DOI: 10.2174/1871527319666200618150046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
36 Zhao B, Wang Y, Liu R, Jia XL, Hu N, An XW, Zheng CG, Chen C, Sun HT, Chen F, Wang JJ, Li XH. Rutaecarpine Ameliorated High Sucrose-Induced Alzheimer's Disease Like Pathological and Cognitive Impairments in Mice. Rejuvenation Res 2021;24:181-90. [PMID: 32892706 DOI: 10.1089/rej.2020.2349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
37 Kim YJ, Sohn E, Kim JH, Na M, Jeong SJ. Catechol-Type Flavonoids from the Branches of Elaeagnus glabra f. oxyphylla Exert Antioxidant Activity and an Inhibitory Effect on Amyloid-β Aggregation. Molecules 2020;25:E4917. [PMID: 33114256 DOI: 10.3390/molecules25214917] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
38 Yang C, Jia X, Zhang L, Li Y, Zhang Z, Li L, Zhang L. Shenqi Xingnao Granules ameliorates cognitive impairments and Alzheimer’s disease-like pathologies in APP/PS1 mouse model. Chinese Herbal Medicines 2020;12:421-9. [DOI: 10.1016/j.chmed.2020.04.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
39 Fang Z, Tang Y, Ying J, Tang C, Wang Q. Traditional Chinese medicine for anti-Alzheimer's disease: berberine and evodiamine from Evodia rutaecarpa. Chin Med 2020;15:82. [PMID: 32774447 DOI: 10.1186/s13020-020-00359-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
40 Xu Y, Zhao M, Han Y, Zhang H. GABAergic Inhibitory Interneuron Deficits in Alzheimer's Disease: Implications for Treatment. Front Neurosci 2020;14:660. [PMID: 32714136 DOI: 10.3389/fnins.2020.00660] [Cited by in Crossref: 42] [Cited by in F6Publishing: 52] [Article Influence: 21.0] [Reference Citation Analysis]
41 Millan MJ, Dekeyne A, Gobert A, Brocco M, Mannoury la Cour C, Ortuno JC, Watson D, Fone KCF. Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs. Neuropharmacology 2020;177:108099. [PMID: 32525060 DOI: 10.1016/j.neuropharm.2020.108099] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
42 Kim YJ, Lim H, Kim J, Na M, Jeong S. Quantitative Analysis of 7 Compounds in Diospyros lotus Leaf Extract and Its Biological Effects on Neuroprotection and Antineuroinflammation. Natural Product Communications 2020;15:1934578X2092485. [DOI: 10.1177/1934578x20924859] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
43 Song Y, Xu W, Zhang X, Ni G. Mechanisms of Electroacupuncture on Alzheimer’s Disease: A Review of Animal Studies. Chin J Integr Med 2020;26:473-80. [DOI: 10.1007/s11655-020-3092-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
44 Yang C, Bao X, Zhang L, Li Y, Li L, Zhang L. Cornel iridoid glycoside ameliorates cognitive deficits in APP/PS1/tau triple transgenic mice by attenuating amyloid-beta, tau hyperphosphorylation and neurotrophic dysfunction. Ann Transl Med 2020;8:328. [PMID: 32355772 DOI: 10.21037/atm.2020.02.138] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
45 Dembitsky VM, Dzhemileva L, Gloriozova T, D'yakonov V. Natural and synthetic drugs used for the treatment of the dementia. Biochem Biophys Res Commun 2020;524:772-83. [PMID: 32037088 DOI: 10.1016/j.bbrc.2020.01.123] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 9.5] [Reference Citation Analysis]
46 Huang D, Peng Y, Ma K, Qing X, Deng X, Li Z, Shao Z. Puerarin Relieved Compression-Induced Apoptosis and Mitochondrial Dysfunction in Human Nucleus Pulposus Mesenchymal Stem Cells via the PI3K/Akt Pathway. Stem Cells Int 2020;2020:7126914. [PMID: 32399049 DOI: 10.1155/2020/7126914] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
47 Muthuraman A, Ramesh M, Venkata Rathina Kumar T. Current Perspectives in the Management of Neurodegenerative Alzheimer’s Disease: Preclinical and Clinical Status. Principles of Neurochemistry 2020. [DOI: 10.1007/978-981-15-5167-3_6] [Reference Citation Analysis]
48 Wang N, Qiu P, Cui W, Yan X, Zhang B, He S. Recent Advances in Multi-target Anti-Alzheimer Disease Compounds (2013 Up to the Present). CMC 2019;26:5684-710. [DOI: 10.2174/0929867326666181203124102] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
49 Won Seok Hyung W, Gon Lee S, Tae Kim K, Soo Kim H. Oncostatin M, a muscle-secreted myokine, recovers high-glucose-induced impairment of Akt phosphorylation by Fos induction in hippocampal neuron cells. NeuroReport 2019;30:765-70. [DOI: 10.1097/wnr.0000000000001271] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
50 Penke B, Bogár F, Paragi G, Gera J, Fülöp L. Key Peptides and Proteins in Alzheimer's Disease. Curr Protein Pept Sci 2019;20:577-99. [PMID: 30605056 DOI: 10.2174/1389203720666190103123434] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
51 Adeniyi AA, Conradie J. Computational insight into the anticholinesterase activities and electronic properties of physostigmine analogs. Future Medicinal Chemistry 2019;11:1907-28. [DOI: 10.4155/fmc-2018-0421] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
52 Amanzadeh E, Esmaeili A, Rahgozar S, Nourbakhshnia M. Application of quercetin in neurological disorders: from nutrition to nanomedicine. Reviews in the Neurosciences 2019;30:555-72. [DOI: 10.1515/revneuro-2018-0080] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
53 Deng G, Wu C, Rong X, Li S, Ju Z, Wang Y, Ma C, Ding W, Guan H, Cheng X, Liu W, Wang C. Ameliorative effect of deoxyvasicine on scopolamine-induced cognitive dysfunction by restoration of cholinergic function in mice. Phytomedicine 2019;63:153007. [PMID: 31301537 DOI: 10.1016/j.phymed.2019.153007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
54 Koola MM, Praharaj SK, Pillai A. Galantamine-Memantine Combination as an Antioxidant Treatment for Schizophrenia. Curr Behav Neurosci Rep 2019;6:37-50. [PMID: 32601581 DOI: 10.1007/s40473-019-00174-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
55 Akbari S, Soodi M, Hajimehdipoor H, Ataei N. Protective effects of Sanguisorba minor and Ferulago angulata total extracts against beta-amyloid induced cytotoxicity and oxidative stress in cultured cerebellar granule neurons. J Herbmed Pharmacol 2019;8:248-55. [DOI: 10.15171/jhp.2019.36] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
56 Dash UC, Kanhar S, Dixit A, Dandapat J, Sahoo AK. Isolation, identification, and quantification of Pentylcurcumene from Geophila repens: A new class of cholinesterase inhibitor for Alzheimer's disease. Bioorg Chem 2019;88:102947. [PMID: 31028989 DOI: 10.1016/j.bioorg.2019.102947] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
57 Ivanov A, Davletshina R, Sharafieva I, Evtugyn G. Electrochemical biosensor based on polyelectrolyte complexes for the determination of reversible inhibitors of acetylcholinesterase. Talanta 2019;194:723-30. [DOI: 10.1016/j.talanta.2018.10.100] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
58 Kim JH, He MT, Kim MJ, Yang CY, Shin YS, Yokozawa T, Park CH, Cho EJ. Safflower ( Carthamus tinctorius L.) seed attenuates memory impairment induced by scopolamine in mice via regulation of cholinergic dysfunction and oxidative stress. Food Funct 2019;10:3650-9. [DOI: 10.1039/c9fo00615j] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 8.0] [Reference Citation Analysis]
59 Masondo N, Stafford G, Aremu A, Makunga N. Acetylcholinesterase inhibitors from southern African plants: An overview of ethnobotanical, pharmacological potential and phytochemical research including and beyond Alzheimer's disease treatment. South African Journal of Botany 2019;120:39-64. [DOI: 10.1016/j.sajb.2018.09.011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 23] [Article Influence: 13.7] [Reference Citation Analysis]
60 Jing L, Wu G, Kang D, Zhou Z, Song Y, Liu X, Zhan P. Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors. Drug Discov Today 2019;24:629-35. [PMID: 30503804 DOI: 10.1016/j.drudis.2018.11.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 6.8] [Reference Citation Analysis]
61 Dos Santos TC, Gomes TM, Pinto BAS, Camara AL, Paes AMA. Naturally Occurring Acetylcholinesterase Inhibitors and Their Potential Use for Alzheimer's Disease Therapy. Front Pharmacol 2018;9:1192. [PMID: 30405413 DOI: 10.3389/fphar.2018.01192] [Cited by in Crossref: 106] [Cited by in F6Publishing: 113] [Article Influence: 26.5] [Reference Citation Analysis]
62 Markowicz-Piasecka M, Huttunen KM, Sikora J. Metformin and its sulphonamide derivative simultaneously potentiateanti-cholinesterase activity of donepezil and inhibit beta-amyloid aggregation. J Enzyme Inhib Med Chem 2018;33:1309-22. [PMID: 30251898 DOI: 10.1080/14756366.2018.1499627] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
63 Wu W, Liang X, Xie G, Chen L, Liu W, Luo G, Zhang P, Yu L, Zheng X, Ji H, Zhang C, Yi W. Synthesis and Evaluation of Novel Ligustrazine Derivatives as Multi-Targeted Inhibitors for the Treatment of Alzheimer's Disease. Molecules 2018;23:E2540. [PMID: 30301153 DOI: 10.3390/molecules23102540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
64 Parsons CG. CNS repurposing - Potential new uses for old drugs: Examples of screens for Alzheimer's disease, Parkinson's disease and spasticity. Neuropharmacology 2019;147:4-10. [PMID: 30165077 DOI: 10.1016/j.neuropharm.2018.08.027] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
65 Tzvetkov NT, Atanasov AG. Natural product-based multitargeted ligands for Alzheimer's disease treatment? Future Medicinal Chemistry 2018;10:1745-8. [DOI: 10.4155/fmc-2018-0146] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
66 Colligris P, Perez de Lara MJ, Colligris B, Pintor J. Ocular Manifestations of Alzheimer's and Other Neurodegenerative Diseases: The Prospect of the Eye as a Tool for the Early Diagnosis of Alzheimer's Disease. J Ophthalmol 2018;2018:8538573. [PMID: 30151279 DOI: 10.1155/2018/8538573] [Cited by in Crossref: 43] [Cited by in F6Publishing: 46] [Article Influence: 10.8] [Reference Citation Analysis]
67 Gascoyne LE, Mullinger KJ, Robson SE, Kumar J, O'Neill GC, Palaniyappan L, Morris PG, Liddle EB, Brookes MJ, Liddle PF. Changes in electrophysiological markers of cognitive control after administration of galantamine. Neuroimage Clin 2018;20:228-35. [PMID: 30090697 DOI: 10.1016/j.nicl.2018.07.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
68 Fu X, Ke M, Yu W, Wang X, Xiao Q, Gu M, Lü Y. Periodic Variation of AAK1 in an Aβ1–42-Induced Mouse Model of Alzheimer’s Disease. J Mol Neurosci 2018;65:179-89. [DOI: 10.1007/s12031-018-1085-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
69 Soheili M, Karimian M, Hamidi G, Salami M. Alzheimer's disease treatment: The share of herbal medicines. Iran J Basic Med Sci 2021;24:123-35. [PMID: 33953850 DOI: 10.22038/IJBMS.2020.50536.11512] [Cited by in F6Publishing: 2] [Reference Citation Analysis]